| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Anna Koza, Márta Wilhelm, László Hiripi, Károly Elekes, Mária Csokny. Embryogenesis of the serotonergic system in the earthworm Eisenia fetida (Annelida, Oligochaeta): immunohistochemical and biochemical studies. The Journal of comparative neurology. vol 497. issue 3. 2006-08-01. PMID:16736470. |
organization of the serotonergic system and changes of the serotonin (5-ht) content were studied during the embryogenesis of the earthworm eisenia fetida, using immunocytochemistry and hplc. |
2006-08-01 |
2023-08-12 |
Not clear |
| Shanker Jha, Rajeev Rajendran, Jasmine Davda, Vidita A Vaidy. Selective serotonin depletion does not regulate hippocampal neurogenesis in the adult rat brain: differential effects of p-chlorophenylalanine and 5,7-dihydroxytryptamine. Brain research. vol 1075. issue 1. 2006-07-31. PMID:16460708. |
we used the serotonin synthesis inhibitor p-chlorophenylalanine (pcpa) or the serotonergic neurotoxin 5,7-dihydroxytryptamine (5,7-dht) to deplete serotonin levels. |
2006-07-31 |
2023-08-12 |
rat |
| Reiji Yoshimura, Sachiko Kaneko, Koji Shinkai, Jun Nakamur. Successful treatment for obsessive-compulsive disorder with addition of low-dose risperidone to fluvoxamine: implications for plasma levels of catecholamine metabolites and serum brain-derived neurotrophic factor levels. Psychiatry and clinical neurosciences. vol 60. issue 3. 2006-07-26. PMID:16732759. |
in short, fluvoxamine enhances the activity of the serotonergic system by inhibiting serotonin transporters, and risperidone decreases that of the dopaminergic system by blocking d2 receptors. |
2006-07-26 |
2023-08-12 |
Not clear |
| Karen H Adams, Elsebeth S Hansen, Lars H Pinborg, Steen G Hasselbalch, Claus Svarer, Søren Holm, Tom G Bolwig, Gitte M Knudse. Patients with obsessive-compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei. The international journal of neuropsychopharmacology. vol 8. issue 3. 2006-07-19. PMID:15801987. |
the pharmacological efficacy of serotonergic-acting drugs suggest that patients with obsessive-compulsive disorder (ocd) may have alterations in their cerebral serotonergic (5-ht) receptor system, and previous neuroimaging studies of ocd patients have shown abnormalities in several fronto-subcortical regions. |
2006-07-19 |
2023-08-12 |
human |
| Lydia Schiller, Markus Donix, Monika Jähkel, Jochen Oehle. Serotonin 1A and 2A receptor densities, neurochemical and behavioural characteristics in two closely related mice strains after long-term isolation. Progress in neuro-psychopharmacology & biological psychiatry. vol 30. issue 3. 2006-07-19. PMID:16412547. |
the presented investigations are aimed to reveal interrelationships between central nervous serotonergic [5-ht] receptor densities and neurochemical as well as behavioural traits in two mice strains. |
2006-07-19 |
2023-08-12 |
mouse |
| Lucas Salomon, Christophe Lanteri, Jacques Glowinski, Jean-Pol Tassi. Behavioral sensitization to amphetamine results from an uncoupling between noradrenergic and serotonergic neurons. Proceedings of the National Academy of Sciences of the United States of America. vol 103. issue 19. 2006-07-19. PMID:16648258. |
we show here that, in naïve animals, noradrenergic and serotonergic systems, besides their behavioral activating effects, inhibit each other by means of the stimulation of alpha1b-adrenergic and 5-ht(2a) receptors and that this mutual inhibition vanishes with repeated injections of d-amphetamine; this uncoupling may be responsible for behavioral sensitization and for an increased reactivity of dopaminergic neurons. |
2006-07-19 |
2023-08-12 |
mouse |
| Lucas Salomon, Christophe Lanteri, Jacques Glowinski, Jean-Pol Tassi. Behavioral sensitization to amphetamine results from an uncoupling between noradrenergic and serotonergic neurons. Proceedings of the National Academy of Sciences of the United States of America. vol 103. issue 19. 2006-07-19. PMID:16648258. |
second, repeated d-amphetamine injections induce an increased reactivity of serotonergic neurons measured by cortical extracellular serotonin (5-ht) levels after the administration of a 5-ht releaser, p-chloroamphetamine. |
2006-07-19 |
2023-08-12 |
mouse |
| Dan J Stein, Christine Lochne. Obsessive-compulsive spectrum disorders: a multidimensional approach. The Psychiatric clinics of North America. vol 29. issue 2. 2006-07-12. PMID:16650712. |
similarly, the involvement of serotonergic neurotransmitters in ocd suggests that these neurotransmitters are central to defining spectrum disorders.again, however, serotonin plays a role in many functions (including impulse control) and mediates many different disorders. |
2006-07-12 |
2023-08-12 |
Not clear |
| Leonardo Rodríguez-Sosa, Gabina Calderón-Rosete, Mercedes Graciela Porras Villalobos, Elena Mendoza Zamora, Víctor Anaya Gonzále. Serotonin modulation of caudal photoreceptor in crayfish. Comparative biochemistry and physiology. Toxicology & pharmacology : CBP. vol 142. issue 3-4. 2006-07-11. PMID:16298168. |
in the first part of our study, we identified serotonergic neurons in the 6th ag by immunostaining using an antibody against serotonin. |
2006-07-11 |
2023-08-12 |
Not clear |
| Bodil Elisabeth Engelmann, Niels Bindslev, Steen Seier Poulsen, Rune Larsen, Mark Berner Hanse. Functional characterization of serotonin receptor subtypes in human duodenal secretion. Basic & clinical pharmacology & toxicology. vol 98. issue 2. 2006-07-07. PMID:16445586. |
our results indicate that in human duodenum 1) 5-ht is a potent stimulator of bumetanide-sensitive secretion, 2) the serotonergic receptor subtype, which acts as the main mediator of 5-ht-induced secretion is different from the 5-ht(2), 5-ht(3), and the 5-ht(4) subtype and, 3) the sensitivity to 5-ht is not altered by helicobacter pylori infection. |
2006-07-07 |
2023-08-12 |
human |
| Kevin M Crisp, Karen A Mesc. Beyond the central pattern generator: amine modulation of decision-making neural pathways descending from the brain of the medicinal leech. The Journal of experimental biology. vol 209. issue Pt 9. 2006-07-07. PMID:16621955. |
the activation pattern of serotonergic brain neurons that we observed during swimming and the 5-ht-immunoreactive staining pattern obtained, suggest that within the head brain 5-ht secretion is massive. |
2006-07-07 |
2023-08-12 |
Not clear |
| Yuko Mohri, Masaki Fumoto, Ikuko Sato-Suzuki, Masahiro Umino, Hideho Arit. Prolonged rhythmic gum chewing suppresses nociceptive response via serotonergic descending inhibitory pathway in humans. Pain. vol 118. issue 1-2. 2006-07-06. PMID:16202533. |
serotonergic (5-ht) neurons are implicated in modulating nociceptive transmission. |
2006-07-06 |
2023-08-12 |
human |
| Sandeep Sood, Janna L Morrison, Hattie Liu, Richard L Horne. Role of endogenous serotonin in modulating genioglossus muscle activity in awake and sleeping rats. American journal of respiratory and critical care medicine. vol 172. issue 10. 2006-07-05. PMID:16020803. |
however, whether endogenous serotonin contributes to gg activation across natural sleep-wake states has not been determined, but is relevant given that serotonergic neurons have decreased activity in sleep and project to pharyngeal motoneurons. |
2006-07-05 |
2023-08-12 |
rat |
| Jian-An Su, Hin-Yeung Tsan. Comparison of weight changes in patients treated with different antidepressants: clinical experiences in Taiwanese patients. Chang Gung medical journal. vol 29. issue 2. 2006-06-29. PMID:16767963. |
this study compared weight changes in patients treated with nassa (noradrenergic and specific serotonergic antidepressant) and ssris (selective serotonin reuptake inhibitors), and investigated possible associated factors. |
2006-06-29 |
2023-08-12 |
Not clear |
| Bettina C Prato. Serotonin syndrome. The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses. vol 38. issue 2. 2006-06-28. PMID:16681290. |
serotonin syndrome is a preventable, drug-related complication that results from increased brainstem serotonin activity, usually precipitated by the use of one or more serotonergic drugs. |
2006-06-28 |
2023-08-12 |
Not clear |
| Ralph Buchert, Rainer Thomasius, Kay Petersen, Florian Wilke, Jost Obrocki, Bruno Nebeling, Lutz Wartberg, Pavlina Zapletalova, Malte Clause. Reversibility of ecstasy-induced reduction in serotonin transporter availability in polydrug ecstasy users. European journal of nuclear medicine and molecular imaging. vol 33. issue 2. 2006-06-22. PMID:16133393. |
previously we reported protracted reductions in the availability of the serotonin transporter (sert), an index of integrity of the axon terminals of brain serotonergic neurons, in sert-rich brain regions in current human ecstasy users. |
2006-06-22 |
2023-08-12 |
human |
| Hagit Cohe. Anxiolytic effect and memory improvement in rats by antisense oligodeoxynucleotide to 5-hydroxytryptamine-2A precursor protein. Depression and anxiety. vol 22. issue 2. 2006-06-22. PMID:16149040. |
serotonergic (5-hydroxytryptamine; 5-ht) mechanisms have been implicated in a number of physiological and pathophysiological processes including mood, anxiety, and cognitive functioning. |
2006-06-22 |
2023-08-12 |
rat |
| P Ken Gillma. A systematic review of the serotonergic effects of mirtazapine in humans: implications for its dual action status. Human psychopharmacology. vol 21. issue 2. 2006-06-22. PMID:16342227. |
a systematic review of published work concerning mirtazapine was undertaken to assess possible evidence of serotonergic effects or serotonin toxicity (st) in humans, because drug toxicity and interaction data from human over-doses is an useful source of information about the nature and potency of drug effects. |
2006-06-22 |
2023-08-12 |
human |
| P Ken Gillma. A systematic review of the serotonergic effects of mirtazapine in humans: implications for its dual action status. Human psychopharmacology. vol 21. issue 2. 2006-06-22. PMID:16342227. |
it appears to exhibit no serotonergic symptoms or toxicity in over-dose by itself, nor is there evidence that it precipitates st in combination with monoamine oxidase inhibitors, as would be expected if it raises intra-synaptic serotonin levels. |
2006-06-22 |
2023-08-12 |
human |
| Marat G Uzbekov, Eduard Y Misionzhnik, Natella M Maximova, Olga P Vertogradov. Biochemical profile in patients with anxious depression under the treatment with serotonergic antidepressants with different mechanisms of action. Human psychopharmacology. vol 21. issue 2. 2006-06-22. PMID:16342231. |
the pharmacodynamics of serotonergic antidepressants that differentially influence serotonin reuptake transporters is poorly investigated. |
2006-06-22 |
2023-08-12 |
Not clear |